Active
Prise en charge des toxicités de la pégaspargase (hors anomalies de la coagulation). Recommandations du comité leucémie de la Société française de lutte contre les cancers de l’enfant et de l’adolescentPrevention and management of pegaspargase associated-toxicities (excluding coagulation abnormalities). Recommendations of the French Society of Children and Adolescent Cancers (Leukemia committee)
Overview
Guidance regarding the management of the most common toxicities (excluding coagulation abnormalities) associated with pegaspargase treatment in children and adolescents is offered.
